[go: up one dir, main page]

SE8500093L - Urokinasderivat - Google Patents

Urokinasderivat

Info

Publication number
SE8500093L
SE8500093L SE8500093A SE8500093A SE8500093L SE 8500093 L SE8500093 L SE 8500093L SE 8500093 A SE8500093 A SE 8500093A SE 8500093 A SE8500093 A SE 8500093A SE 8500093 L SE8500093 L SE 8500093L
Authority
SE
Sweden
Prior art keywords
urokinase
pct
fibrinogen
derivatives
sec
Prior art date
Application number
SE8500093A
Other languages
English (en)
Other versions
SE8500093D0 (sv
SE442022B (sv
Inventor
A V Maximenko
E G Tischenko
V P Torchilin
V N Smirnov
E I Chazov
Original Assignee
Vsesojuznyj Kardiologitsches
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vsesojuznyj Kardiologitsches filed Critical Vsesojuznyj Kardiologitsches
Publication of SE8500093D0 publication Critical patent/SE8500093D0/sv
Publication of SE8500093L publication Critical patent/SE8500093L/sv
Publication of SE442022B publication Critical patent/SE442022B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8500093A 1983-05-10 1985-01-09 Urokinasderivat bestaende av urokinas bundet till fibrinogen SE442022B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU833590957A SU1128601A1 (ru) 1983-05-10 1983-05-10 Урокиназа,иммобилизированна на фибриногене

Publications (3)

Publication Number Publication Date
SE8500093D0 SE8500093D0 (sv) 1985-01-09
SE8500093L true SE8500093L (sv) 1985-01-09
SE442022B SE442022B (sv) 1985-11-25

Family

ID=21063322

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8500093A SE442022B (sv) 1983-05-10 1985-01-09 Urokinasderivat bestaende av urokinas bundet till fibrinogen

Country Status (8)

Country Link
US (1) US4564596A (sv)
JP (1) JPS60501239A (sv)
DE (1) DE3490222T1 (sv)
GB (1) GB2150576B (sv)
IT (1) IT1199522B (sv)
SE (1) SE442022B (sv)
SU (1) SU1128601A1 (sv)
WO (1) WO1984004536A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400653D0 (en) * 1984-01-11 1984-02-15 Beecham Group Plc Conjugates
US4783330A (en) * 1984-11-15 1988-11-08 New England Medical Center Hospitals, Inc. Monoclonal antibodies to activated platelets
CA1335361C (en) * 1989-05-24 1995-04-25 Andrei Z. Budzynski Thrombus-targeted complexes of plasminogen activator and fibrin fragments
US5632986A (en) * 1991-05-09 1997-05-27 The University Of Washington Phospholipid-targeted thrombolytic agents
CA2091544A1 (en) * 1992-03-26 1993-09-27 Shing F. Kwan Stabilization of functional proteins
US10127295B2 (en) * 2009-06-05 2018-11-13 Microsoft Technolofy Licensing, Llc Geographic co-location service for cloud computing
US8577892B2 (en) * 2009-06-05 2013-11-05 Microsoft Corporation Utilizing affinity groups to allocate data items and computing resources
RU2674032C1 (ru) * 2018-06-05 2018-12-04 федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский национальный исследовательский университет информационных технологий, механики и оптики" (Университет ИТМО) Способ получения урокиназы, энтрапированной в коллоидный магнитный керамический нанокомпозитный материал

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3544427A (en) * 1968-04-18 1970-12-01 Century Lab Inc Method of production of urokinase
US4029767A (en) * 1971-09-24 1977-06-14 Choay S.A. Pharmaceutical compositions of stable urokinase-heparin complexes and methods for use thereof
DE2431342C3 (de) * 1973-07-27 1978-10-26 Behringwerke Ag, 3550 Marburg Verfahren zur Messung des Plasminogengehaltes durch Bestimmung der Bildung von Fibrin in einer Probe
JPS6043116B2 (ja) * 1978-02-21 1985-09-26 株式会社ミドリ十字 ウロキナ−ゼ誘導体
JPS54147916A (en) * 1978-05-12 1979-11-19 Sumitomo Chem Co Ltd Preparation of urokinase injection
GB2038337B (en) * 1978-12-21 1983-01-19 Green Cross Corp Process which comprises separation of urokinases having different molecular weights
SU1022988A1 (ru) * 1979-09-28 1983-06-15 Всесоюзный кардиологический научный центр АМН СССР Стабилизированна урокиназа,обладающа тромболитической активностью,и способ ее получени
US4381346A (en) * 1979-11-13 1983-04-26 Huasin Syed S Isolation of plasminogen activators useful as therapeutic and diagnostic agents

Also Published As

Publication number Publication date
IT1199522B (it) 1988-12-30
SU1128601A1 (ru) 1985-07-15
GB2150576A (en) 1985-07-03
IT8441570A0 (it) 1984-05-09
GB2150576B (en) 1987-02-25
SE8500093D0 (sv) 1985-01-09
GB8500165D0 (en) 1985-02-13
SE442022B (sv) 1985-11-25
WO1984004536A1 (en) 1984-11-22
US4564596A (en) 1986-01-14
JPS60501239A (ja) 1985-08-08
IT8441570A1 (it) 1985-11-09
DE3490222T1 (de) 1985-05-02
JPH026513B2 (sv) 1990-02-09

Similar Documents

Publication Publication Date Title
ES2058614T3 (es) 1,2-ciclohexilaminoarilaminadas utiles como agentes analgesicos.
FI840748A (fi) Kinolonkarbonsyror, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella aemnen.
FI873363A (fi) Foerfarande foer framstaellning av laekemedel med antitumoeraktivitet.
ATE145201T1 (de) Dihydro-isoquinolinderivate
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
DE3880047D1 (de) Zusammensetzung eines zusatzes.
FI91160B (sv) Förfarande för framställning av modifierat humant t-PA-protein
ATE139569T1 (de) Modifizierter, menschlicher gewebeplasminogenaktivator und seine herstellung
FI925988A0 (fi) Foerfarande foer framstaellning av b-laktamer
PT86362A (en) Process for the preparation of anxiolytic compositions containing n-(1-azabicyclo ]2,2.2."-oct-3-yl) benzamides and thiobenzamides
SE8404065D0 (sv) Novel biologically active compounds
SE8500093L (sv) Urokinasderivat
SE8302554D0 (sv) New azepinoindoles, their production and pharmaceutical compositions containing them
PT85317A (fr) Procede pour l:obtention d:imunotoxines par couplage d:un anticorps avec une proteine trichosanthine ou trickokirine
ATE112320T1 (de) Sekretormutante von escherichia coli.
ZA872664B (en) Six-membered heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazines
EP0346741A3 (en) Fibrin(ogen) derivatives, process for preparing them and their use
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
OA07270A (fr) Dérivés N-(vinblastinoyl-23) d'acide aminés, leur préparation et leur application thérapeutique.
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
ES8603441A1 (es) Procedimiento para preparar un derivado de fenotiazina
AU553493B2 (en) 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives
ES8705847A1 (es) Procedimiento para preparar nuevos derivados de n-(2-hidro- xialquil)-aminoacidos
IT1178489B (it) Vettore clonante, procedimento per la sua costruzione e procedimento di concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante
ATE89555T1 (de) 3-substituierte 1-(2-halogen-alkoxybenzolsulfonyl)-3-heteroaryl-harnstoffe.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8500093-3

Effective date: 19910117

Format of ref document f/p: F